Article
[Chronic neutrophilic leukemia/chronic eosinophilic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2023
Kawashima Ichiro, Kirito Keita
Abstract excerpt
Chronic neutrophilic leukemia (CNL) is a clonal disorder that is characterized by increasing mature neutrophils. Colony stimulating factor 3 receptor (CSF3R) T618I mutation was frequently identified in patients with CNL and is defined as a molecular marker of the disease. Ruxolitinib, a JAK2 inhibitor, provided a promising therapeutic effect in a phase II study. In particular, ruxolitinib was more efficient for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
